Literature DB >> 7983731

Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.

N Chazal1, B Gay, C Carrière, J Tournier, P Boulanger.   

Abstract

The role of the matrix protein (MA) of human immunodeficiency virus type 1 in intracellular transport, assembly, and extracellular release of Gag polyprotein precursor (Pr55gag) was investigated by deletion mutagenesis of the MA domain of recombinant Gag precursor expressed in baculovirus-infected cells. In addition, three carboxy-terminally truncated forms of the Gag precursor, representing mainly the MA, were constructed. One corresponded to an MA with a deletion of its last 12 residues (amb120), while the others corresponded to the entire MA with an additional sequence from the N-terminal portion of the CA (amb143 and och180). Deletions within the MA central region (residues 41 to 78) appeared to be detrimental to Gag particle assembly and budding from the plasma membrane. A slightly narrower domain, between amino acids 41 and 68, was found to be critical for soluble Gag secretion. Mutations which totally or partially deleted one or the other of the two polybasic signals altered the transport of N-myristylated Gag precursor to the plasma membrane. In coexpression with wild-type Gag precursor, a discrete trans-dominant negative effect on wild-type Gag particle assembly and release was observed with deletion mutants located in the central MA region (residues 41 to 78). A more significant negative effect was obtained with the two recombinant proteins of amb120 and och180, which redirected the Gag particle assembly pathway from the plasma membrane compartment to intracellular vesicles (amb120) and to the nuclear compartment (och180).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7983731      PMCID: PMC188584          DOI: 10.1128/JVI.69.1.365-375.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant.

Authors:  J M Kaplan; G Mardon; J M Bishop; H E Varmus
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

2.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

3.  Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus.

Authors:  A Rein; M R McClure; N R Rice; R B Luftig; A M Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production.

Authors:  E O Freed; J M Orenstein; A J Buckler-White; M A Martin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection.

Authors:  S Crawford; S P Goff
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

9.  Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15.

Authors:  F D Veronese; R Rahman; T D Copeland; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

10.  Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.

Authors:  H R Gelderblom; E H Hausmann; M Ozel; G Pauli; M A Koch
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

View more
  21 in total

1.  Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.

Authors:  Y Morikawa; W H Zhang; D J Hockley; M V Nermut; I M Jones
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

2.  Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation.

Authors:  S A González; A Burny; J L Affranchino
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

3.  The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.

Authors:  J H Simon; R A Fouchier; T E Southerling; C B Guerra; C K Grant; M H Malim
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  A cell-line-specific defect in the intracellular transport and release of assembled retroviral capsids.

Authors:  S D Parker; E Hunter
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells.

Authors:  S S Hong; L Karayan; J Tournier; D T Curiel; P A Boulanger
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

6.  Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.

Authors:  M Bouyac; M Courcoul; G Bertoia; Y Baudat; D Gabuzda; D Blanc; N Chazal; P Boulanger; J Sire; R Vigne; B Spire
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates.

Authors:  P Spearman; L Ratner
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17.

Authors:  Y Morikawa; T Kishi; W H Zhang; M V Nermut; D J Hockley; I M Jones
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions.

Authors:  A Ono; M Huang; E O Freed
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

10.  Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.

Authors:  E O Freed; M A Martin
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.